{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T04:00:30Z","timestamp":1777953630131,"version":"3.51.4"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,4]]},"DOI":"10.7759\/cureus.108246","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T16:09:42Z","timestamp":1777910982000},"source":"Crossref","is-referenced-by-count":0,"title":["A Novel Neurofibromatosis Type 1 (NF1) Frameshift Mutation Associated With Atypical Hypotensive Pheochromocytoma: A Case Report"],"prefix":"10.7759","author":[{"given":"Rojda","family":"Kotan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ensar Gazi","family":"G\u00f6\u00e7er","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Sait","family":"Ko\u00e7","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Neurofibromatosis","author":"Friedman JM","year":"2025","unstructured":"Friedman JM. Neurofibromatosis. GeneReviews. Adam MP, Bick S, Mirzaa GM, et al (ed): University of Washington, Seattle (WA); 2025."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-3204","article-title":"Neurofibromatosis type 1 revisited","volume":"123","author":"Williams VC","year":"2009","unstructured":"Williams VC, Lucas J, Babcock MA, Gutmann DH, Korf B, Maria BL. Neurofibromatosis type 1 revisited. Pediatrics. 2009, 123:124-33. 10.1542\/peds.2007-3204","journal-title":"Pediatrics"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.4","article-title":"Neurofibromatosis type 1","volume":"3","author":"Gutmann DH","year":"2017","unstructured":"Gutmann DH, Ferner RE, Listernick RH, Korf BR, Wolters PL, Johnson KJ. Neurofibromatosis type 1. Nat Rev Dis Primers. 2017, 3:17004. 10.1038\/nrdp.2017.4","journal-title":"Nat Rev Dis Primers"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/GIM.0b013e3181bf15e3","article-title":"Clinical and genetic aspects of neurofibromatosis 1","volume":"12","author":"Jett K","year":"2010","unstructured":"Jett K, Friedman JM. Clinical and genetic aspects of neurofibromatosis 1. Genet Med. 2010, 12:1-11. 10.1097\/GIM.0b013e3181bf15e3","journal-title":"Genet Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(07)70075-3","article-title":"Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective","volume":"6","author":"Ferner RE. Neurofibromatosis 1 and neurofibromatosis 2","year":"2007","unstructured":"Ferner RE. Neurofibromatosis 1 and neurofibromatosis 2. Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective. Lancet Neurol. 2007, 6:340-51. 10.1016\/S1474-4422(07)70075-3","journal-title":"Lancet Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders JW","year":"2014","unstructured":"Lenders JW, Duh QY, Eisenhofer G, et al.. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014, 99:1915-42. 10.1210\/jc.2014-1498","journal-title":"J Clin Endocrinol Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1806651","article-title":"Pheochromocytoma and paraganglioma","volume":"381","author":"Neumann HP","year":"2019","unstructured":"Neumann HP, Young WF Jr, Eng C. Pheochromocytoma and paraganglioma. N Engl J Med. 2019, 381:552-65. 10.1056\/NEJMra1806651","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-5347(05)68171-2","article-title":"von Recklinghausen's disease and pheochromocytomas","volume":"162","author":"Walther MM","year":"1999","unstructured":"Walther MM, Herring J, Enquist E, Keiser HR, Linehan WM. von Recklinghausen's disease and pheochromocytomas. J Urol. 1999, 162:1582-6.","journal-title":"J Urol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-010-1090-z","article-title":"Neurofibromatosis type 1 (NF1) and pheochromocytoma: prevalence, clinical and cardiovascular aspects","volume":"303","author":"Zinnamosca L","year":"2011","unstructured":"Zinnamosca L, Petramala L, Cotesta D, et al.. Neurofibromatosis type 1 (NF1) and pheochromocytoma: prevalence, clinical and cardiovascular aspects. Arch Dermatol Res. 2011, 303:317-25. 10.1007\/s00403-010-1090-z","journal-title":"Arch Dermatol Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13163","article-title":"Pheochromocytoma and paraganglioma in patients with neurofibromatosis type 1","volume":"86","author":"Gruber LM","year":"2017","unstructured":"Gruber LM, Erickson D, Babovic-Vuksanovic D, Thompson GB, Young WF Jr, Bancos I. Pheochromocytoma and paraganglioma in patients with neurofibromatosis type 1. Clin Endocrinol (Oxf). 2017, 86:141-9. 10.1111\/cen.13163","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1124\/pr.56.3.1","article-title":"Catecholamine metabolism: a contemporary view with implications for physiology and medicine","volume":"56","author":"Eisenhofer G","year":"2004","unstructured":"Eisenhofer G, Kopin IJ, Goldstein DS. Catecholamine metabolism: a contemporary view with implications for physiology and medicine. Pharmacol Rev. 2004, 56:331-49. 10.1124\/pr.56.3.1","journal-title":"Pharmacol Rev"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a010118","article-title":"NF1 gene and neurofibromatosis 1","volume":"151","author":"Rasmussen SA","year":"2000","unstructured":"Rasmussen SA, Friedman JM. NF1 gene and neurofibromatosis 1. Am J Epidemiol. 2000, 151:33-40. 10.1093\/oxfordjournals.aje.a010118","journal-title":"Am J Epidemiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/humu.20728","article-title":"Human genome variation and pharmacogenetics","volume":"29","author":"Gottlieb B","year":"2008","unstructured":"Gottlieb B. Human genome variation and pharmacogenetics. Hum Mutat. 2008, 29:453-5. 10.1002\/humu.20728","journal-title":"Hum Mutat"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2017.12.001","article-title":"Genotype-phenotype correlation in NF1: evidence for a more severe phenotype associated with missense mutations affecting NF1 codons 844-848","volume":"102","author":"Koczkowska M","year":"2018","unstructured":"Koczkowska M, Chen Y, Callens T, et al.. Genotype-phenotype correlation in NF1: evidence for a more severe phenotype associated with missense mutations affecting NF1 codons 844-848. Am J Hum Genet. 2018, 102:69-87. 10.1016\/j.ajhg.2017.12.001","journal-title":"Am J Hum Genet"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2008.059329","article-title":"Mosaicism in sporadic neurofibromatosis type 1: variations on a theme common to other hereditary cancer syndromes?","volume":"45","author":"Kehrer-Sawatzki H","year":"2008","unstructured":"Kehrer-Sawatzki H, Cooper DN. Mosaicism in sporadic neurofibromatosis type 1: variations on a theme common to other hereditary cancer syndromes?. J Med Genet. 2008, 45:622-31. 10.1136\/jmg.2008.059329","journal-title":"J Med Genet"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards S","year":"2015","unstructured":"Richards S, Aziz N, Bale S, et al.. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015, 17:405-24. 10.1038\/gim.2015.30","journal-title":"Genet Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx1153","article-title":"ClinVar: improving access to variant interpretations and supporting evidence","volume":"46","author":"Landrum MJ","year":"2018","unstructured":"Landrum MJ, Lee JM, Benson M, et al.. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018, 46:D1062-7. 10.1093\/nar\/gkx1153","journal-title":"Nucleic Acids Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-020-02199-3","article-title":"The Human Gene Mutation Database (HGMD\u00ae): optimizing its use in a clinical diagnostic or research setting","volume":"139","author":"Stenson PD","year":"2020","unstructured":"Stenson PD, Mort M, Ball EV, et al.. The Human Gene Mutation Database (HGMD\u00ae): optimizing its use in a clinical diagnostic or research setting. Hum Genet. 2020, 139:1197-207. 10.1007\/s00439-020-02199-3","journal-title":"Hum Genet"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2019.07.004","article-title":"The diagnosis and management of neurofibromatosis type 1","volume":"103","author":"Ly KI","year":"2019","unstructured":"Ly KI, Blakeley JO. The diagnosis and management of neurofibromatosis type 1. Med Clin North Am. 2019, 103:1035-54. 10.1016\/j.mcna.2019.07.004","journal-title":"Med Clin North Am"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/487200-a-novel-neurofibromatosis-type-1-nf1-frameshift-mutation-associated-with-atypical-hypotensive-pheochromocytoma-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T16:09:43Z","timestamp":1777910983000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/487200-a-novel-neurofibromatosis-type-1-nf1-frameshift-mutation-associated-with-atypical-hypotensive-pheochromocytoma-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.108246","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,4]]}}}